← Back to Clinical Trials
Recruiting NCT04839796

NCT04839796 Northeastern Taiwan Community Medicine Research Cohort

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04839796
Status Recruiting
Phase
Sponsor Chang Gung Memorial Hospital
Condition Cohort Study
Study Type OBSERVATIONAL
Enrollment 20,000 participants
Start Date 2013-08
Primary Completion 2043-08

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20,000 participants in total. It began in 2013-08 with a primary completion date of 2043-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The cohort study on disease prevention and health promotion in the northeastern region of Taiwan is a trial dedicated to large-scale generational research in northeastern Taiwan beginning in the August of 2013. The program aims to develop a comprehensive and integrated approach to disease prevention and community health. The researcher's cohort organizes healthcare outreaches for participants over the age of 20 residing in 64 administrative areas in Keelung city and new Taipei city. The researcher's sessions include a comprehensive health examination, health-related questionnaires, and disease awareness seminars. Biological samples, questionnaire information, and medical data obtained from researcher's participants are stored in researcher's core laboratory. Depersonalized data and samples are shared with partnering trials approved by the Chang Gung Memorial Hospital Institutional review board. The investigators are currently partnered with 18 clinical trials spanning across multiple disciplines such as urology, hepatology, metabolism, physical therapy, and psychology.

Eligibility Criteria

Inclusion Criteria: 1. Residing in Keelung city and new Taipei city. 2. Mobile health and mental health 3. Participating in healthcare outreaches Exclusion Criteria: 1. Under 20 years old 2. Participant without judgment 3. Participant has HIV

Contact & Investigator

Central Contact

Yu Chiau Shyu, PHD

✉ yuchiaushyu@gmail.com

📞 02-24329292

Principal Investigator

Yu Chiau Shyu, PHD

PRINCIPAL INVESTIGATOR

Community Medicine Research Center,Chang Gung Memorial Hospital,Keelung branch

Frequently Asked Questions

Who can join the NCT04839796 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Cohort Study. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04839796 currently recruiting?

Yes, NCT04839796 is actively recruiting participants. Contact the research team at yuchiaushyu@gmail.com for enrollment information.

Where is the NCT04839796 trial being conducted?

This trial is being conducted at Keelung, Taiwan.

Who is sponsoring the NCT04839796 clinical trial?

NCT04839796 is sponsored by Chang Gung Memorial Hospital. The principal investigator is Yu Chiau Shyu, PHD at Community Medicine Research Center,Chang Gung Memorial Hospital,Keelung branch. The trial plans to enroll 20,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology